"Rather than worry about global uncertainy, we believe successful long-term stock investing is about identifying and owning businesses on the verge of a dramatic increase in profits -- such as Check Point Software (CHKP)," says Alexander Green.

The editor of The Oxford Club explains, "Founded in 1993 by three members of the Israeli military who linked top-secret computer networks, Check Point is the worldwide leader in securing the internet, providing customers with uncompromising protection against all manner of cyber threats.

Continue reading Cyber Threats Boost Check Point Software (CHKP)

Cyber Threats Boost Check Point Software (CHKP) originally appeared on BloggingStocks on Mon, 28 Mar 2011 17:30:00 EST. Please see our terms for use of feeds.

This post is one in a series in which more than 60 newsletter advisors share their Top Stock Picks for 2011. This special report is courtesy of TheStockAdvisors.com.

"The smartphone revolution -- with web-browsing, video-watching, music-streaming mobile devices -- has made bandwidth a scarce resource," says small cap specialist Ian Wyatt.

The editor of Small Cap Investor PRO explains, "That's where Allot Communications (ALLT) comes in. Allot is an Israeli company that develops deep packet inspection (DPI) technology specifically designed to manage bandwidth use.

Continue reading Top Picks 2011: Allot Communications (ALLT)

Top Picks 2011: Allot Communications (ALLT) originally appeared on BloggingStocks on Wed, 29 Dec 2010 17:00:00 EST. Please see our terms for use of feeds.

Continue reading Teva (TEVA): A 'Sure Pick' for the Long-Term

Teva (TEVA): A 'Sure Pick' for the Long-Term originally appeared on BloggingStocks on Tue, 20 Jul 2010 12:30:00 EST. Please see our terms for use of feeds.

"Israel-based Shamir Optical Industries (SHMR) makes lenses for eyeglasses, focusing on progressive lenses (also called no-line bifocals); it also sells finished lenses directly to opticians and provides design services to other lens manufacturers," says income specialist Carla Pasternak.

The editor of High Yield International asserts, "The shares of this small cap company are attractively valued and carry a juicy 6% yield.

"Like many foreign companies, Shamir pays dividends once per year. The stock paid a $0.61 dividend in December 2009, which was a +150% increase over the 2008 dividend and translates to a solid 6.4% yield.

Continue reading Shamir Optical (SHMR): Visionary Value?

Shamir Optical (SHMR): Visionary Value? originally appeared on BloggingStocks on Wed, 12 May 2010 12:30:00 EST. Please see our terms for use of feeds.

"Cellcom Israel (CEL), Israel's leading mobile-phone company, delivered decent fourth-quarter results, highlighted by modest +4% top-line growth but more robust +11% net income growth," says Amy Calistri.

The editor of The Daily Paycheck explains, "That caps off a fiscal year that saw impressive expense control, and a shift to higher-margin offerings. So the full-year results were even more dramatic than the quarterly trend, with net income soaring almost +20%."

Continue reading Cellcom Israel (CEL): Dividends and Shekels

Cellcom Israel (CEL): Dividends and Shekels originally appeared on BloggingStocks on Fri, 02 Apr 2010 10:40:00 EST. Please see our terms for use of feeds.

The editor of Global Investing says, "Its software lets companies and government entities manage their workforce and customer service by fully integrating call centers, customer relationship management (CRM), scheduling, location tracking, and mobile telephony links with workers in the field and their waiting customers."

Continue reading Click Software (CKSW): Israeli Firm Eyes Workforce Management

Click Software (CKSW): Israeli Firm Eyes Workforce Management originally appeared on BloggingStocks on Wed, 10 Mar 2010 13:00:00 EST. Please see our terms for use of feeds.

"The health care picks in our growth portfolio should prosper whatever the outcome of the raging health care debate," suggests growth stock specialist Stephen Leeb.

In The Complete Investor, he explains, "That's because they're leveraged to demographic realities, and in particular to the tide of aging baby boomers," Here, he reviews on portfolio holding -- Teva Pharmaceuticals (NASDAQ: TEVA).

Leeb says, "Israel-based Teva Pharmaceutical is the world's largest manufacturer of generic drugs. Capitalized at $49 billion, Teva pulled in some $11 billion in revenues in 2008, with generic drugs contributing more than two-thirds of those sales.

Continue reading Teva (TEVA): Baby-boomers give boost to generics

Teva (TEVA): Baby-boomers give boost to generics originally appeared on BloggingStocks on Wed, 14 Oct 2009 11:00:00 EST. Please see our terms for use of feeds.

"Reflecting the stability and maturity of its economy and financial markets, Israel was recently upgraded to developed-market status," says fund expert Mark Salzinger.

In The Investor's ETF Report, he looks at iShares MSCI Israel Capped Investable Market ETF (NYSE: EIS), noting, "For a nation of just more than seven million people, Israel generates exceptional economic productivity."

"GDP per capita was recently $28,200, good for 49th in the world, very close to established developed markets like New Zealand and Italy.

Continue reading Shalom: Say hello to the first all-Israeli ETF

Shalom: Say hello to the first all-Israeli ETF originally appeared on BloggingStocks on Wed, 30 Sep 2009 11:00:00 EST. Please see our terms for use of feeds.

The Cabot Benjamin Graham Value Letter focuses on stocks that meet the strict value criteria of the legendary investor. Here, J. Royden Ward looks to Teva Pharmaceutical (NASDAQ: TEVA), noting, "Teva is based in Israel and develops, makes and sells generic and proprietary-branded (store brand) drugs."

The advisor explains, "The company is one of the largest generic drug-producing companies in the world and, in addition, sells active ingredients to other pharmaceutical companies.

"Teva's aggressive acquisition and product development programs are driving strong sales growth. The company recently purchased U.S.-based Barr Pharmaceuticals for $7.5 billion. Barr will increase Teva's generic drug sales significantly in the U.S. and parts of Europe.

Continue reading Teva: A 'Ben Graham' selection

Teva: A 'Ben Graham' selection originally appeared on BloggingStocks on Fri, 18 Sep 2009 13:30:00 EST. Please see our terms for use of feeds.

"As is the case with most countries in the Middle East, Israel rarely comes up in discussions of global 'safe havens', notes John Christy.

The editor of The Forbes International Investment Report explains, "But so far this year, Israel has been a pretty good place to hide from Wall Street's woes." Here he looks at one Israeli favorite, Cellcom Israel (NYSE: CEL).

"Putting stereotypes about risk aside, Israel offers a lot of interesting opportunities, even for fairly conservative investors. Cellcom Israel is a prime example. The company is Israel's largest mobile phone service provider, with sales of $1.6 billion in 2007.

"Since February 2007, the company has had a dual listing on both the New York and Tel Aviv stock exchanges. Discount Investment Corp. Ltd., one of Israel's largest business groups, owns just over 50% of the company.

"With 3.1 million subscribers, Cellcom has a 34% share of Israel's mobile telecom services market. Roughly three-quarters of Cellcom's subscribers are individuals, and the remaining 25% are corporate customers.

Continue reading Shalom: Forbes expert calls on Cellcom Israel (CEL)

Shalom: Forbes expert calls on Cellcom Israel (CEL) originally appeared on BloggingStocks on Thu, 19 Jun 2008 10:39:00 EST. Please see our terms for use of feeds.

"Analysts estimate the worldwide market for generics will increase from $75 billion to $125 billion by 2012," says Michael Shulman.

In his ChangeWave Biotech Investor he states, "The key question for us is: Who is going to make the most money from these expirations? And the 800-pound gorilla in this market is our long-time holding, Teva Pharmaceuticals (NASDAQ: TEVA).

"Teva is the largest and best generics company in the world with $9.4 billion in sales in 2007 and the gap between it and its competitors is growing. Teva has 331 products on the market, 65% more than its closest competitor.

"More importantly, based on its business model of a mix of proprietary and generic drugs, the company's operating margins are 10 points higher than competitors and that gap is widening. In fact, in the United States, the number of prescriptions filled with Teva generics is 50% more than its closest competitor.

"Be clear on this point: When it comes to generics, size does matter. The more a company sells, the more profit and cash it has available to do research and acquire more generics to add to its product list -- and the beat goes on.

Continue reading Teva: The 800-pound gorilla of generics

Teva: The 800-pound gorilla of generics originally appeared on BloggingStocks on Fri, 13 Jun 2008 14:00:00 EST. Please see our terms for use of feeds.

For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.

"Elbit Medical Imaging Ltd. (NASDAQ: EMITF) -- my top speculative idea for 2008 -- is about to change its name to Elbit Imaging, following shareholder approval," notes Vivian Lewis in her Global Investing Pro. Vivian was the top performer in last year's Best Stocks report, with her selection of DryShips rising nearly 400%.

"EMITF is a subsidiary of Europe Israel (M.M.S.) Ltd., which operates in the construction, operation, management and sale of shopping and entertainment centers in Israel, Central and Eastern Europe, and India.

"The company also owns hotels, primarily in major European cities, and manages and sells hotels through its Elscint Ltd. subsidiary.

"The company is also involved in investments in the research and development, production, and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, through its subsidiary InSightec Ltd.

Continue reading Best Stocks for 2008: Top stock picker picks Elbit Medical (EMITF)

Best Stocks for 2008: Top stock picker picks Elbit Medical (EMITF) originally appeared on BloggingStocks on Mon, 31 Dec 2007 18:00:00 EST. Please see our terms for use of feeds.